PLGA Nanoparticle-Based Formulations to Cross the Blood–Brain Barrier for Drug Delivery: From R&D to cGMP

The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain, hindering treatment of central nervous system (CNS) disorders such as acute ischemic stroke, brain tumors, and human immunodeficiency virus (HIV)-1-associated neurocognitive disorders. Poly(lactic-co-glycolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhi, Kaining, Raji, Babatunde, Nookala, Anantha R., Khan, Mohammad Moshahid, Nguyen, Xuyen H., Sakshi, Swarna, Pourmotabbed, Tayebeh, Yallapu, Murali M., Kochat, Harry, Tadrous, Erene, Pernell, Shelby, Kumar, Santosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067506/
https://www.ncbi.nlm.nih.gov/pubmed/33917577
http://dx.doi.org/10.3390/pharmaceutics13040500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067506/
https://www.ncbi.nlm.nih.gov/pubmed/33917577
http://dx.doi.org/10.3390/pharmaceutics13040500

Ejemplares similares